The Goldman Sachs Group, Inc. 13D and 13G filings for CERo Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 3:45 pm Unchanged |
2022-12-30 | 13G | CERo Therapeutics Holdings, Inc. CERO |
GOLDMAN SACHS GROUP INC GS |
0 0.000% |
0 (Unchanged) |
Filing |